State-based and demographic variation in parent-reported medication rates for attention-deficit/hyperactivity disorder, 2007-2008.
State-based and demographic variation in parent-reported medication rates for attention-deficit/hyperactivity disorder, 2007-2008.
复制标题
DOI：
10.5888/pcd9.120073
复制
发表时间：
2013
影响因子：
5.5
通讯作者：
Kogan MD
中科院分区：
文献类型：
--
作者：
Visser SN;Blumberg SJ;Danielson ML;Bitsko RH;Kogan MD
药物是治疗注意力缺陷/多动障碍（ADHD）最有效的方法，ADHD是一种常见的儿童神经行为障碍。我们使用2007-2008年全国儿童健康调查的数据，按州和性别分层年龄计算美国4 - 17岁儿童中父母报告的ADHD和药物治疗的加权估计。各州的ADHD药物治疗率从内华达州的33%到密西西比州的79%不等；在每个年龄段，男孩的药物多动症发生率都高于女孩。需要对ADHD药物治疗因素进行基于州的调查，我们的研究结果可能为这些公共卫生工作提供信息。
Medication is the most effective treatment of attention-deficit/hyperactivity disorder (ADHD), a common neurobehavioral disorder of childhood. We used data from the 2007-2008 National Survey of Children’s Health to calculate weighted estimates of parent-reported ADHD and medication treatment among US children aged 4 to 17 years, by state and sex-stratified age. State-based rates of ADHD medication treatment ranged from 33% in Nevada to 79% in Mississippi; rates of medicated ADHD were higher among boys than girls at every age. State-based investigations of ADHD medication treatment factors are needed, and our findings may inform these public health efforts.
影响因子：
17.7
作者：
Zuvekas, Samuel H.;Vitiello, Benedetto
通讯作者：
Vitiello, Benedetto